Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy

OBJECTIVES: Obesity and diabetes are strong risk factors that drive the development of type I endometrial cancers. Recent epidemiological evidence suggests that metformin may lower cancer risk and reduce rates of cancer deaths among diabetic patients. In order to better understand metformin's a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cantrell, Leigh A., Zhou, Chunxiao, Mendivil, Alberto, Malloy, Kimberly M., Gehrig, Paola A., Bae-Jump, Victoria L.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2789879/
https://ncbi.nlm.nih.gov/pubmed/19822355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.09.024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares